Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
Ester BenaigesVictòria Ceperuelo-MallafréSandra GuaitaElsa Maymó-MasipAna MadeiraDavid GómezVictor HernándezIsabel VilasecaCarla MermaXavier Leon VintroXimena TerraJoan VendrellFrancesc Xavier Avilés-JuradoSonia Fernández-VeledoPublished in: Head & neck (2024)
Survivin/BIRC5 might be independently associated with the risk of recurrence in patients with HNSCC.